Perinatal air pollution exposure and development of asthma from birth to age 10 years

Hind Sbihi1, Lillian Tamburic2, Mieke Koehoorn2

  • 1School of Population and Public Health, University of British Columbia, Vancouver, BC, Canada hind.sbihi@ubc.ca.

Insights

Childhood asthma onset is linked to air pollution exposure. Traffic pollutants like nitrogen dioxide increased pre-school asthma risk, especially for low-birthweight infants.

Area of Science:

  • Environmental Health
  • Pediatric Epidemiology
  • Respiratory Medicine

Background:

  • Childhood asthma development is linked to urban air pollution, but findings are inconsistent.
  • Understanding the impact of specific air pollutants on asthma onset is crucial for public health interventions.

Purpose of the Study:

  • To investigate the association between perinatal air pollution exposure and asthma onset in children.
  • To differentiate impacts during pre-school (0-5 years) and school-age (6-10 years) periods.

Main Methods:

  • A population-based birth cohort of 65,254 children in Vancouver (1999-2002) was followed until age 10.
  • Asthma cases were matched with controls; associations with air pollutants (nitric oxide, nitrogen dioxide, carbon monoxide) were analyzed using conditional logistic regression.
  • Exposure was estimated using inverse-distance weighting (IDW), land use regression, and proximity methods.

Main Results:

  • Increased asthma risk during pre-school years was associated with traffic pollutants (NO: 1.06, NO2: 1.09, CO: 1.05 per IQR increase).
  • Enhanced impacts were observed in children with low birth weight.
  • Associations were independent of residential greenness.

Conclusions:

  • Within-city air pollution variation is associated with new-onset asthma during early childhood.
  • Traffic-related air pollution is a significant risk factor for pre-school asthma development.

Related Concept Videos

Asthma-I: Introduction01:29

Asthma-I: Introduction

Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
3.7K
Asthma: Pathogenesis and Management01:20

Asthma: Pathogenesis and Management

Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
1.7K
Asthma-II: Pathophysiology and Classification01:26

Asthma-II: Pathophysiology and Classification

Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
4.8K
Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics01:23

Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics

Respiratory symptoms, such as congestion and cough, commonly accompany respiratory tract conditions. Various medications, such as antitussives, expectorants, and mucolytics, play crucial roles in providing relief.
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla.  Benzonatate operates peripherally within the respiratory tract by...
1.6K
Breathing01:05

Breathing

The process of breathing, inhaling and exhaling, involves the coordinated movement of the chest wall, the lungs, and the muscles that move them. Two muscle groups with important roles in breathing are the diaphragm, located directly below the lungs, and the intercostal muscles, which lie between the ribs. When the diaphragm contracts, it moves downward, increasing the volume of the thoracic cavity and creating more room for the lungs to expand. When the intercostal muscles contract, the ribs...
66.4K
Chronic Obstructive Pulmonary Disease-II: Pathophysiology01:20

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
5.0K